Rahul Parikh

14PUBLICATIONS

81CO-AUTHORS

Radiation therapyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|May 07, 2026

Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE).

|Mar 19, 2026

Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer.

Eun-Ryeong Hahm, Bruce L Jacobs, Krishna B Singh

|Feb 25, 2026

Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax® on Fatty Acid Synthesis in Prostate Cancer.

Eun-Ryeong Hahm, Bruce L Jacobs, Krishna B Singh

|Jan 23, 2026

Delta-Like Ligand 3 Expression by Immunohistochemistry in Rare Neuroendocrine Neoplasms and Associated Response to Off-Label Tarlatamab Treatment.

Timothy Schieber, Jacob Hobbs, Jessica Campaign-Mauser

|Jan 20, 2026

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.

Mary-Ellen Taplin, Irbaz Bin Riaz, R Bryan Rumble

|Sep 04, 2025

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Clinical Insights.

Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi

Pageof 3

Frequent Collaborators

R Bryan Rumble

Rohan Garje

Thomas A Hope

Leonard J Appleman

Irbaz Bin Riaz

Sumanta Pal

Hamid Emamekhoo

Eun-Ryeong Hahm

M Hassan Murad

Sebastien J Hotte

Frequent Collaborators

R Bryan Rumble

Rohan Garje

Thomas A Hope

Leonard J Appleman